Articles related to Jeff Conn

Scenario: VU could garner up to $422MM, as fight against neurospsych disorders, degenerative diseases advances.

[Updated] Less than three years into their mission, Deerfield, Mountain Group and founders press forward.

The word is just getting out about new entrant in Tennessee biopharm ecosystem.

Lynch cites workforce challenges and the need for more collaboration throughout the region as essential to lift Nashville from lower tier of life-science centers

Vanderbilt pharma program inches cautiously toward tech transfer, while key faculty member keeps firm hand on the tiller